Latest Medicines for Malaria Venture Stories
Seven New Grant Investments for $15.3 Million to Tackle Malaria, Chagas Disease and Dengue, which is Dramatically on the Rise TOKYO, Sept.
Pro-Bono Work Using Freeslate CM3 Reaction Screening System Achieved Near 100 Percent Chiral Resolution for Important Drug Intermediate SUNNYVALE, Calif (PRWEB)
Scientists at Oregon Health & Science University and the Portland VA Medical Center have developed a drug that may represent one of the world's best hopes for treating and preventing malaria — a disease that kills more than one million people each year.
Medicines for Malaria Venture has developed a framework to evaluate the risk of resistance for the antimalarial compounds in its portfolio.
The discovery of a new class of dual-acting antimalarial compounds - the imidazolopiperazines (IZPs) – was published in the journal Science online, at the Science Express website today1.
A drug-resistant strain of malaria could spread from southeast Asia to Africa in as little as three months, which puts millions of children at risk, according to a warning from a leading expert Wednesday.
PHILADELPHIA and LONDON, Jan.